ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Seeing is believing: Stem cell therapy – KTVA

Continue reading

2018-04-10 Michael Zand NEWS

Qiu Chang Wu ’18 Named NSF Graduate Research Fellow – Colorado College News


KTVA

Seeing is believing: Stem cell therapy
KTVA
Seeing is believing: Stem cell therapy. Sunday, April 8th 2018, 11:16 pm AKDT by Ivanhoe Newswire. Updated: Monday, April 9th 2018, 4:01 pm AKDT. MIAMI, Fla. (Ivanhoe Newswire) — It’s estimated that nearly 1.3 Americans are legally blind. Now a doctor …

Continue reading

2018-04-09 Michael Zand NEWS

A new study shows that some are ‘immune’ to CRISPR. What does it mean for biology’s breakthrough editor? – Massive


Colorado College News

Qiu Chang Wu ’18 Named NSF Graduate Research Fellow
Colorado College News
Qiu Chang Wu ’18 has been awarded a National Science Foundation Graduate Research Fellowship, one of two Colorado College seniors to receive the highly competitive fellowship this year. The award will support Wu’s research interests in systems and …

Continue reading

2018-04-09 Michael Zand NEWS

A new study shows that some are ‘immune’ to CRISPR. What does it mean for biology’s breakthrough editor? – Massive


Massive

A new study shows that some are ‘immune’ to CRISPR. What does it mean for biology’s breakthrough editor?
Massive
Even for those Cas9 proteins from humans, we can probably find ways to decrease their chance that they are recognized by the immune system, even though this is yet to be done. To take things further, not all CRISPR systems found in bacteria use Cas9 to …

and more »

Continue reading

2018-04-09 Michael Zand NEWS

Immunotherapy for Triple-Negative Breast Cancer – OncLive


Massive

A new study shows that some are ‘immune’ to CRISPR. What does it mean for biology’s breakthrough editor?
Massive
Even for those Cas9 proteins from humans, we can probably find ways to decrease their chance that they are recognized by the immune system, even though this is yet to be done. To take things further, not all CRISPR systems found in bacteria use Cas9 to …

and more »

Continue reading

2018-04-09 Michael Zand NEWS

Our April issue – blockchain, top copyright firms, CRISPR patents, Russian parallel imports, marijuana marks – Managing Intellectual Property (blog)

Managing Intellectual Property (blog)Our April issue – blockchain, top copyright firms, CRISPR patents, Russian parallel imports, marijuana marksManaging Intellectual Property (blog)The issue features our widely-read IP STARS copyright rankings for … Continue reading

2018-04-09 Michael Zand NEWS

Dr. Nanus on Managing Side Effects from Immunotherapy in RCC – OncLive

OncLiveDr. Nanus on Managing Side Effects from Immunotherapy in RCCOncLiveDavid M. Nanus, MD, medical oncologist, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses managing side effects from immunotherapy in renal cell carcinoma (RCC). Mo… Continue reading

2018-04-09 Michael Zand NEWS

UCLA Researchers Use CRISPR Approach to Profile Genomic Variants in High-Throughput Manner – GenomeWeb

UCLA Researchers Use CRISPR Approach to Profile Genomic Variants in High-Throughput MannerGenomeWebCRISPR-Cas9 editing through homology directed repair (HDR) requires incorporating the desired sequence variants encoded in a DNA template into the genomi… Continue reading

2018-04-09 Michael Zand NEWS
  • 1
  • …
  • 276
  • 277
  • 278
  • 279
  • 280
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Immunotherapy for Triple-Negative Breast Cancer
OncLive
What happens is with immunotherapy for breast cancer, because it’s not a very immunogenic disease, it’s really important to do it early. We saw a doubling or tripling of pathologic complete response rates in the neoadjuvant I-SPY trial. In the first …

and more »